Share

    


Home / Search Results

Search Results

You searched for:

ACCC Director Cancer Care Delivery and Health Policy Matt Devino, MPH, lays out the four key differences between the OCM and EOM that interested applicants need to consider.
With total spending on U.S. cancer care projected to rise 34 percent from 2015-2030 to $245 billion, biosimilars can play a role in helping reduce those costs. Learn how Biden’s executive order on promoting competition in the American economy will require the FDA's biosimilars approval framework to be clearer and easier to follow.
At the end of last month, the Centers for Medicare & Medicaid Services (CMS) released the much-anticipated calendar year (CY) 2020 Medicare Payment rules. Touted by CMS as an effort to “empower patients with price transparency and increase competition to lower costs for Medicare beneficiaries,” the proposed Outpatient Prospective Payment System (OPPS) rule for 2020 introduces new price transparency …
Each year, in conjunction with the ACCC Annual Meeting and Cancer Center Business Summit, ACCC members come to Washington, D.C., for our Capitol Hill Day. Across the board, these members tell us how much they’ve enjoyed this unique opportunity to meet in small groups, or even one-on-one, with their legislators and congressional staffers to talk about challenges—and successes—at their cancer programs …
On October 25, 2018, President Trump addressed a campaign promise ahead of the heavily contested mid-term elections regarding his administration’s continued drug pricing reform efforts. Healthcare leadership under the Trump administration unveiled a three-prong plan using the Center for Medicare and Medicaid Innovation (CMMI) to test three ways to lower the costs of drugs, aimed largely at Medicare …
Autumn signals seasonal changes, but one constant is the annual assessment of the policy implications of the proposed Medicare payment rules for the upcoming calendar year. In this 2019 rule-making cycle, access to care and the overall reimbursement and healthcare delivery landscape have the potential to undergo a drastic shift. In September ACCC submitted comments to both the 2019 Physician Fee Schedule …
On July 25, 2018, the Centers for Medicare & Medicaid Services (CMS) released the CY 2019 Outpatient Prospective Payment System (OPPS) proposed rule, and we are seeing several efforts to continue the push towards “site neutral” payments in off-campus provider-based departments (PBDs). This rule was issued weeks after the CY 2019 Physician Fee Schedule (PFS) proposed rule, and the atypical lag time …
In August 2015 the Health Resources and Services Administration (HRSA) released its much-anticipated “mega-guidance” on the 340B Drug Pricing Program, proposing new limits on the program but stopping short of a complete overhaul, prompting mixed reviews from stakeholders.